These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 25597386)

  • 1. Aclidinium bromide plus formoterol for the treatment of chronic obstructive pulmonary disease.
    Lal C; Strange C
    Expert Opin Pharmacother; 2015 Feb; 16(3):427-34. PubMed ID: 25597386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Rogliani P; Matera MG
    Expert Opin Pharmacother; 2013 Apr; 14(6):775-81. PubMed ID: 23472632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopharmacological profile of the fixed-dose combination of aclidinium bromide and formoterol fumarate in the management of chronic obstructive pulmonary disease.
    Babu KS; Morjaria JB
    Ther Adv Respir Dis; 2015 Apr; 9(2):56-68. PubMed ID: 25754881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease.
    Haley R; Gupta N; Sethi S
    Expert Rev Clin Pharmacol; 2020 Feb; 13(2):103-113. PubMed ID: 31951778
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term safety of aclidinium bromide/formoterol fumarate fixed-dose combination: Results of a randomized 1-year trial in patients with COPD.
    Donohue JF; Soong W; Wu X; Shrestha P; Lei A
    Respir Med; 2016 Jul; 116():41-8. PubMed ID: 27296819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy.
    Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG
    Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised double-blind, placebo-controlled, long-term extension study of the efficacy, safety and tolerability of fixed-dose combinations of aclidinium/formoterol or monotherapy in the treatment of chronic obstructive pulmonary disease.
    D'Urzo A; Rennard S; Kerwin E; Donohue JF; Lei A; Molins E; Leselbaum A
    Respir Med; 2017 Apr; 125():39-48. PubMed ID: 28340861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aclidinium bromide and formoterol fumarate as a fixed-dose combination in COPD: pooled analysis of symptoms and exacerbations from two six-month, multicentre, randomised studies (ACLIFORM and AUGMENT).
    Bateman ED; Chapman KR; Singh D; D'Urzo AD; Molins E; Leselbaum A; Gil EG
    Respir Res; 2015 Aug; 16(1):92. PubMed ID: 26233481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany.
    Rivero-Ferrer E; Olesen M; Plana E; Aguado J; Saigí-Morgui N; Rubino A; Daoud SZ; Lei A; Perez-Gutthann S; Schink T; Kristiansen NS; Hallas J; Pottegård A; Rebordosa C
    Clin Drug Investig; 2022 Apr; 42(4):319-331. PubMed ID: 35290649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease.
    Avdeev SN; Trushenko NV
    Ter Arkh; 2019 Mar; 91(3):76-85. PubMed ID: 31094464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Cazzola M; Page CP; Matera MG
    Expert Opin Pharmacother; 2013 Jun; 14(9):1205-14. PubMed ID: 23566013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aclidinium bromide combined with formoterol inhibits remodeling parameters in lung epithelial cells through cAMP.
    Lambers C; Costa L; Ying Q; Zhong J; Lardinois D; Dekan G; Schuller E; Roth M
    Pharmacol Res; 2015 Dec; 102():310-8. PubMed ID: 26546746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual bronchodilator therapy with aclidinium bromide/formoterol fumarate for chronic obstructive pulmonary disease.
    D'Urzo T; Donohue JF; Price D; Miravitlles M; Kerwin E
    Expert Rev Respir Med; 2015 Oct; 9(5):519-32. PubMed ID: 26366803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence base.
    D'Urzo AD; Singh D; Donohue JF; Chapman KR
    Ther Adv Respir Dis; 2019; 13():1753466619850725. PubMed ID: 31096854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aclidinium bromide/formoterol fumarate as a treatment for COPD: an update.
    D'Urzo AD; Singh D; Donohue JF; Chapman KR; Wise RA
    Expert Rev Respir Med; 2021 Sep; 15(9):1093-1106. PubMed ID: 34137664
    [No Abstract]   [Full Text] [Related]  

  • 16. Searching for the synergistic effect between aclidinium and formoterol: From bench to bedside.
    Cazzola M; Calzetta L; Ora J; Puxeddu E; Rogliani P; Matera MG
    Respir Med; 2015 Oct; 109(10):1305-11. PubMed ID: 26303336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization of the interaction between aclidinium bromide and formoterol fumarate on human isolated bronchi.
    Cazzola M; Calzetta L; Page CP; Rogliani P; Facciolo F; Gavaldà A; Matera MG
    Eur J Pharmacol; 2014 Dec; 745():135-43. PubMed ID: 25446566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in clinically important deterioration in chronic obstructive pulmonary disease with aclidinium/formoterol.
    Singh D; D'Urzo AD; Chuecos F; Muñoz A; Garcia Gil E
    Respir Res; 2017 May; 18(1):106. PubMed ID: 28558833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The discovery and development of aclidinium bromide for the treatment of chronic obstructive pulmonary disease.
    Malerba M; Radaeli A; Santini G; Morjaria J; Mores N; Mondino C; Macis G; Montuschi P
    Expert Opin Drug Discov; 2018 Jun; 13(6):563-577. PubMed ID: 29616842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aclidinium bromide/formoterol fixed-dose combination therapy for COPD: the evidence to date.
    Moitra S; Bhome AB; Brashier BB
    Drug Des Devel Ther; 2015; 9():1989-99. PubMed ID: 25897208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.